Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.

Saved in:
Bibliographic Details
Title: Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
Authors: Haas-Kogan DA; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA., Aboian MS; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT., Minturn JE; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Leary SES; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA.; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA., Abdelbaki MS; Department of Pediatrics, Washington University School of Medicine, St Louis, MO., Goldman S; Phoenix Children's Hospital, Phoenix, AZ.; University of Arizona College of Medicine, Phoenix, AZ., Elster JD; Division of Hematology Oncology, Department of Pediatrics, Rady Children's Hospital, University of California, San Diego, San Diego, CA., Kraya A; Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA., Lueder MR; Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA., Ramakrishnan D; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT., von Reppert M; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.; University of Leipzig, Leipzig, Germany., Liu KX; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA., Rokita JL; Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA., Resnick AC; Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA., Solomon DA; Department of Pathology, University of California, San Francisco, San Francisco, CA., Phillips JJ; Department of Pathology, University of California, San Francisco, San Francisco, CA.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA., Prados M; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA.; Department of Pediatrics, University of California, San Francisco, San Francisco, CA., Molinaro AM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA., Waszak SM; Laboratory of Computational Neuro-Oncology, Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.; Department of Neurology, University of California, San Francisco, San Francisco, CA.; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway., Mueller S; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA.; Department of Pediatrics, University of California, San Francisco, San Francisco, CA.; Department of Neurology, University of California, San Francisco, San Francisco, CA.; Department of Pediatrics, University of Zurich, Zurich, Switzerland.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Feb 01; Vol. 42 (4), pp. 441-451. Date of Electronic Publication: 2023 Nov 17.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.23.01838